HAVN Life Logo White

The Future of Psychedelic Medicine

Our Story

Find out what inspires us to support mental health disorders.

Our Mission

Supporting innovative therapies to help humans thrive.

Our Team

Multi-disciplinary collaboration
creating positive experiences and outcomes.


Using evidence-informed research, we want to unlock human performance and empower people to achieve their full potential.


Psychedelic medicine is the frontier of mental health and wellness

Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.

350 Million

People globally are affected by a form of depression.

1 Trillion

Dollars lost annually in global workforce productivity due to depression and anxiety.


Formulas standardized across clinical studies of psychedelic compounds.

HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.

Press Releases

HAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsil

Through the Partnership, the Company will seek Health Canada approval to supply naturally-derived psilocybin for legal and therapeutic use via the Special Access Program Vancouver, …

Read More →
Press Releases

HAVN Life Secures Supply Agreement with Atman Retreats

This new partnership will see the distribution of the Company’s standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Atman retreats in Jamaica Vancouver, …

Read More →
Press Releases

HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia

The successful shipment of white label natural health products will expand the Company’s global retail footprint Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) …

Read More →
Scroll to Top